At present, bone grafts are the standard treatment to enhance bone healing in many clinical situations. Unfortunately, there are many drawbacks associated with current methods of assisted osteogenesis. Certain bone growth factors called Bone Morphogenetic Proteins (BMPs) have been shown to improve osteoinduction. Therefore, their use as an alternative for bone grafts is compelling. An appropriate delivery vehicle for these growth factors is critical in their effectiveness. This study tests Polylactide-co-Glycolide as a potential carrier.

• This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.

Creator

• Hammond, James Jeffrey

Publisher

• Worcester Polytechnic Institute

Identifier

• 01D284M

Advisor

• Rulfs, Jill

Year

• 2001

Date created

• 2001-01-01

Resource type

• Major Qualifying Project

Major

• Biology & Biotechnology

Rights statement

• In Copyright